QuVa Pharma, Inc. 2022-10-05 Health moderate FDA
Health · FDA · Recall #FDA-D-1544-2022
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV… Recall
Issued October 5, 2022 · QuVa Pharma, Inc.
In October 2022, QuVa Pharma, Inc. recalled the oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).
What you should do
- 1 Stop using oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact QuVa Pharma, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- QuVa Pharma, Inc.
- Category
- Health
- Recall date
- October 5, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-1544-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- QuVa Pharma, Inc. has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.